ImageVerifierCode 换一换
格式:PDF , 页数:111 ,大小:1.45MB ,
资源ID:685629      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-685629.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(DIN V ENV 13730-2-2003 Healthcare Informatics - Blood transfusion related messages - Part 2 Product related messages (BTR-PROD) German version ENV 13730-2 2002 Text English《保健信息学 输.pdf)为本站会员(cleanass300)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

DIN V ENV 13730-2-2003 Healthcare Informatics - Blood transfusion related messages - Part 2 Product related messages (BTR-PROD) German version ENV 13730-2 2002 Text English《保健信息学 输.pdf

1、DEUTSCHE NORM Oktober 2003VornormMedizinische InformatikFr die Bluttransfusion bentigte NachrichtenTeil 2: Fr die Erzeugnisse bentigte NachrichtenDeutsche Fassung ENV 13730-2:2002, Text EnglischVENV 13730-2ICS 35.240.80Healthcare Informatics Blood transfusion related messages Part 2: Product related

2、 messages (BTR-PROD);German version ENV 13730-2:2002, Text EnglishEine Vornorm ist das Ergebnis einer Normungsarbeit, das wegen bestimmter Vorbehalte zum Inhalt oderwegen des gegenber einer Norm abweichenden Aufstellungsverfahrens vom DIN noch nicht als Normherausgegeben wird.Zur vorliegenden Vornor

3、m wurde kein Entwurf verffentlicht.Erfahrungen mit dieser Vornorm sind erbeten ang190 vorzugsweise als Datei per E-Mail an nameddin.de in Form einer Tabelle. Die Vorlage dieserTabelle kann im Internet unter http:/www.din.de/stellungnahme abgerufen werden;g190 oder in Papierform an den Normenausschus

4、s Medizin (NAMed) im DIN Deutsches Institut frNormung e. V., 10772 Berlin (Hausanschrift: Burggrafenstr. 6, 10787 Berlin).Nationales VorwortDiese Vornorm enthlt unter Bercksichtigung des Prsidialbeschlusses 13/1983 den englischen Original-text der europischen Vornorm ENV 13730-2, Ausgabe September 2

5、002. Diese europische Vornormwurde in der WG I Information Models des CEN/TC 251 Medizinische Informatik erarbeitet. Der Fach-bereich G Medizinische Informatik und insbesondere die Mitarbeiter des Arbeitsausschusses G 1Modellierung des Normenausschusses Medizin (NAMed) im DIN haben an der Erarbeitun

6、g mitgewirkt.Fortsetzung Seite 2und 109 Seiten ENVNormenausschuss Medizin (NAMed) im DIN Deutsches Institut fr Normung e. V.DIN Deutsches Institut fr Normung e.V. .Jede Art der Vervielfltigung, auch auszugsweise,Ref. Nr. DIN V ENV 13730-2:2003-10nur mit Genehmigung des DIN Deutsches Institut fr Norm

7、ung e. V., Berlin, gestattet. Preisgr. 31 Vertr.-Nr. 2331Alleinverkauf der Normen durch Beuth Verlag GmbH, 10772 BerlinVornormDIN V ENV 13730-2:2003-102Fr die im Abschnitt 2 zitierten Internationalen Normen wird im Folgenden auf die entsprechendenDeutschen Normen hingewiesen:ISO 5218:1977 siehe DIN

8、ISO 5218:1980(Schreibfehler in der Norm, dort als ISO 5281:1997 bezeichnet).ISO/IEC 7826-1 und ISO/IEC 7826-2 wurden im Jahr 2001 zurckgezogen.Nationaler Anhang NA(informativ)LiteraturhinweiseDIN ISO 5218, Informationsverarbeitung Datenaustausch Darstellung des Geschlechts von Menschen.Vornorm EUROP

9、ISCHE VORNORMEUROPEAN PRESTANDARDPRNORME EUROPENNEENV 13730-2September 2002ICS 35.240.80Deutsche FassungMedizinische Informatik Fr die Bluttransfusion bentigte Nachrichten Teil 2: Fr die Erzeugnisse bentigte NachrichtenDeutsche Fassung ENV 13730-2:2002Healthcare Informatics Blood transfusionrelated

10、messages Part 2: Product relatedmessages (BTR-PROD)Diese Europische Vornorm (ENV) wurde vom CEN am 18. September 2001 als eine knftige Norm zur vorlufigen Anwendungangenommen.Die Gltigkeitsdauer dieser ENV ist zunchst auf drei Jahre begrenzt. Nach zwei Jahren werden die Mitglieder des CEN gebeten, i

11、hreStellungnahmen abzugeben, insbesondere ber die Frage, ob die ENV in eine Europische Norm umgewandelt werden kann.Die CEN-Mitglieder sind verpflichtet, das Vorhandensein dieser ENV in der gleichen Weise wie bei einer EN anzukndigen und die ENV aufnationaler Ebene unverzglich in geeigneter Weise ve

12、rfgbar zu machen. Es ist zulssig, entgegenstehende nationale Normen bis zurEntscheidung ber eine mgliche Umwandlung der ENV in eine EN (parallel zur ENV) beizubehalten.CEN-Mitglieder sind die nationalen Normungsinstitute von Belgien, Dnemark, Deutschland, Finnland, Frankreich, Griechenland, Irland,I

13、sland, Italien, Luxemburg, Malta, Niederlande, Norwegen, sterreich, Portugal, Schweden, Schweiz, Spanien, der Tschechischen Republikund dem Vereinigten Knigreich.EUROPISCHES KOMITEE FR NORMUNGEUROPEAN COMMITTEE FOR STANDARDIZATIONCOMIT EUROPEN DE NORMALISATIONManagement-Zentrum: rue de Stassart, 36

14、B-1050 Brssel 2002 CEN Alle Rechte der Verwertung, gleich in welcher Form und in welchemVerfahren, sind weltweit den nationalen Mitgliedern von CEN vorbehalten.Ref. Nr. ENV 13730-2:2002 DVornorm ENV 13730-2:2002 (E)2ContentsPageForeword. 5Introduction 51 Scope. 62 Normative references. 83 Terms, def

15、initions and abbreviations. 94 Requirements 154.1 General conformance requirements. 154.2 Implementation recommendations . 165 Communication roles. 165.1 General. 165.1.1 Sending role requirements . 165.1.2 Receiving role requirements. 165.2 Use case diagram and scenarios (General use case) . 165.3

16、Group 2: Message sequences . 185.3.1 Blood component production message domain . 186 Requirements and General Message Descriptions 196.1 Conformance requirements 196.2 General Message Descriptions 206.3 Blood/blood component collection request message. 216.3.1 Scope of this message . 216.3.2 Blood/b

17、lood component collection request message. 236.4 Blood/blood component classification request message . 236.4.1 Scope of this message . 236.4.2 Blood/blood component classification request message . 266.5 Blood/blood component classification report message 266.5.1 Scope of the message 266.5.2 Blood/

18、blood component classification report message 296.6 Blood/blood component collected delivery note message . 296.6.1 Scope of this message . 296.6.2 Blood/blood component collected delivery note message . 326.7 Blood component request message. 326.7.1 Scope of this message . 326.7.2 Blood component r

19、equest message. 346.8 Blood component manufactured delivery note message . 346.8.1 Scope of this message . 346.8.2 Blood component manufactured delivery note message . 376.9 Blood component processing request message 376.9.1 Scope of this message . 376.9.2 Blood component processing request message

20、406.10 Blood component processed delivery note message. 406.10.1 Scope of this message . 406.10.2 Blood component processed delivery note message. 437 Domain information model (DIM) 437.1 Introduction. 437.1.1 The modelling approach. 447.1.2 Presentation of attributes from generalisations 447.2 Gene

21、ral message subsystem. 477.2.1 Requested item message. 48Vornorm ENV 13730-2:2002 (E)3Page7.2.2 Issued item message 497.2.3 Blood/blood components collector 507.2.4 Blood components manufacturer 507.2.5 Blood components dispenser517.2.6 Blood components processor517.3 Specific message subsystem527.3

22、.1 Original message identification .537.3.2 Blood/blood component collection request message .547.3.3 Blood/blood component classification request message 547.3.4 Blood/blood component classification report message.557.3.5 Blood/blood component collected delivery note message557.3.6 Blood component

23、request message .567.3.7 Blood component manufactured delivery note message567.3.8 Blood component processing request message.577.3.9 Blood component processed delivery note message .577.4 Communicating parties subsystem .587.4.1 Message sender597.4.2 Message receiver597.5 Healthcare agent subsystem

24、.607.5.1 Healthcare agent in context 617.5.2 healthcare agent relationship617.5.3 Healthcare agent 3.30.627.5.4 healthcare party 3.33 627.5.5 Healthcare organisation 3.32 637.5.6 Healthcare professional 3.34 637.6 Collected item subsystem .647.6.1 Collected item647.6.2 Blood component 3.9 657.6.3 Sa

25、mple 3.45 667.7 Requested item .677.7.1 Requested item .677.7.2 Requested blood component information .687.7.3 Delivery location697.8 Issued item subsystem707.8.1 Issued blood component.717.8.2 Blood component characteristic727.8.3 Blood component unit .727.8.4 Quantity of blood component 737.8.5 Is

26、sued blood component administrative details 737.8.6 Issued blood component information 747.8.7 Unit (container) characteristic .747.9 Payment guarantor subsystem .757.9.1 Payment details.767.9.2 Payment guarantor767.9.3 Payment authorisation 777.10 Laboratory investigation subsystem777.10.1 Laborato

27、ry investigation (ENV 1613) 787.10.2 Requested laboratory investigation (ENV 1613).787.10.3 Laboratory investigation report (ENV 1613)787.11 Blood donor subsystem.787.11.1 Blood donor 3.13.797.11.2 Clinical information 3.18797.11.3 Clinical information item807.12 Common subclasses.807.12.1 Address .

28、807.12.2 Event date and time 817.12.3 General message information.817.12.4 Identifier.82Vornorm ENV 13730-2:2002 (E)4Page7.12.5 Language details 827.12.6 Measurement 827.12.7 Message identification 837.12.8 Party identifier. 837.12.9 Person name details. 847.12.10 Structured address . 847.12.11 Stru

29、ctured person name. 857.12.12 Time interval . 857.12.13 Time period. 857.12.14 Unstructured address . 867.12.15 Unstructured name details 867.12.16 Value of quantity. 86Annex A (informative) How to read the models. 87Annex B (informative) Compound and simple data types Rationale and how to use the d

30、ata typesin messages 92Annex C (informative) Guide to usage of CEN/TC 251/ENV 1613 97Bibliography . 107Index 108Vornorm ENV 13730-2:2002 (E)5ForewordThis document (ENV 13730-2:2002) has been prepared by Technical Committee CEN/TC 251 Healthinformatics, the secretariat of which is held by SIS.It was

31、developed by Project Team 32 under mandate M/255 given by the European Commission and theEuropean Free Trade Association, order voucher BC/CEN/97/23.This is Part 2 of a multipart standard (ENV 13730) under the general heading Health Informatics Bloodtransfusion related messages with the following pa

32、rts:g190 Part 1: Subject of care related messagesg190 Part 2: Production related messagesAnnex C of this European Prestandard is normative, all other annexes are informative.According to the CEN/CENELEC Internal Regulations, the national standards organizations of the followingcountries are bound to

33、 announce this European Prestandard: Austria, Belgium, Czech Republic, Denmark,Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway,Portugal, Spain, Sweden, Switzerland and the United Kingdom.IntroductionPart 2 of this European Prestandard (ENV) provides

34、a set of messages that enables the electronic transfer ofmessages in the blood transfusion domain.The motivation for this ENV derives from a combination of the following factors:Electronic messages developed in the Healthcare Informatics domain contain sensitive healthcare informationabout specified

35、 individuals that requires a high level of confidence both in the parties sending and receivingmessages and that the information being made available is unchanged. Standards are required to facilitateelectronic transfer of blood transfusion related messages and reports between the many systems curre

36、ntlyused. Information transferred in the blood transfusion related messages and any reports passing betweenhealthcare parties form part of the information system of each of the communicating parties. Electronictransfer of these blood transfusion related messages and reports reduces the need for manu

37、al entry and therisk of transcription errors. It also results in greater efficiency leading to better healthcare provision.This ENV has been developed following the methods recommended in the CEN Report on MedicalInformatics Methodology for the development of healthcare messages (CR 12587:1996). How

38、ever, inaccord with the decisions of CEN TC251 WGI, a different modelling technique has been used. This is a subsetof the Unified Modelling Language (UML) as documented in Annex A.This ENV specifies messages in a syntax independent form. Its requirements for conformance define theminimum acceptable

39、content and structure for these messages. Compliant messages can be developed in avariety of implementation syntaxes and these syntax specific implementations may be the subject of futureStandards.Vornorm ENV 13730-2:2002 (E)6This ENV is directly relevant to suppliers of computer systems for use in

40、development. Its provisions are alsorelevant to those planning, specifying, procuring or implementing information systems for use in the bloodtransfusion domain.Particular note for implementers: Some attributes may have the same title but modified in meaning for use inPart two than in Part one.1 Sco

41、peTransfusion of blood 3.7 and blood components 3.9 (blood products) to subjects of care 3.48 is a medicalactivity that is subject to many legal regulations and constraints. Many problems may be encountered duringtreatment due to immunological conditions, transmitted diseases, sustainability and oth

42、er difficulties. Mistakesand failures may have serious or even fatal consequences. Minimising human activity through the increaseduse of data processing and automated messaging will introduce an additional safety mechanism.This ENV specifies general messages 3.41 for electronic information interchan

43、ge between computersystems used by healthcare 3.29 parties 3.33 in the blood transfusion 3.16 domain. The content andstructure of the messages specified in this ENV have been developed with the aim of optimising the safety ofblood transfusion activity and to facilitate compliance monitoring and secu

44、re audit trails 3.2.This ENV is applicable to blood transfusion related messages including those for:g190 the collection of blood/blood components 3.22 from blood donorg190 manufacturing 3.40 and processing 3.44 of blood componentsg190 classification 3.19 of blood donationsg190 issue of blood compon

45、ents to the blood components dispenserWithin the blood transfusion process there are a number of actors:(1) The blood components dispenser 3.10 obtains blood components and blood products from one or moreproviders, then stores and dispenses them to the user, in some countries this function is known

46、as theHospital Blood Bank. This actor may appear as a separate entity, or as subdivision, within either the classproducer or user. In certain circumstances communication may be required with a different blood componentsdispenser or with all dispensers within another region or a country.(2) The blood

47、 components manufacturer 3.11 prepares blood components for transfusion from donor bloodand issues blood components to the blood components dispenser 3.10 a blood components processor or toanother blood components manufacturer. In many countries the production process utilises a special bloodtransfu

48、sion data system providing internal communications between the subdivisions (blood collection,collected blood classification 3.17, manufacturing of blood components 3.40, processing of bloodcomponents 3.52), and issues blood components to a blood components dispenser.(3) The blood components process

49、or 3.12 receives blood components from a blood componentsmanufacturer 3.11 for processing into blood products.(4) The Laboratory service provider 3.39 provides a laboratory service (serological, biochemical,bacteriological and virological analyses), to classify a sample of donor blood received from the blood/bloodcomponents collector. The laboratory can be an integral part of the healthcare organisation.(5) The blood/blood components collector 3

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1